Orchid surges on receiving USFDA approval for Eszopiclone Tablets ANDA

20 Jun 2014 Evaluate

Orchid Chemicals & Pharmaceuticals is currently trading at Rs. 76.65, up by 4.80 points or 6.68% from its previous closing of Rs. 71.85 on the BSE.

The scrip opened at Rs. 75.30 and has touched a high and low of Rs. 77.25 and Rs. 75.10 respectively. So far 2,49,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 81.60 on 10-Jun-2014 and a 52 week low of Rs. 35.00 on 02-Aug-2013.

Last one week high and low of the scrip stood at Rs. 77.25 and Rs. 68.50 respectively. The current market cap of the company is Rs. 539.00 crore.The promoters holding in the company stood at 32.28% while Institutions and Non-Institutions held 7.01% and 56.13% respectively.

Orchid Chemicals & Pharmaceuticals, the Chennai-based pharma major, has received approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Eszopiclone Tablets, 1 mg, 2 mg, and 3 mg strengths.

Orchid Chemicals & Pharmaceuticals is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs. The company was incorporated in the year 1992 as a 100% export-oriented unit (EOU).

Orchid Pharma Share Price

1032.10 38.05 (3.83%)
08-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6050.00
Cipla 1383.40
Zydus Lifesciences 1006.10
Lupin 1616.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.